{
  "id": 2036796,
  "title": "Red Robin Stock Is in the Middle of a Tasty Turnaround You Don’t Want to Miss",
  "url": "https://urgent.news/2026/08/18/red-robin-stock-is-in-the-middle-of-a-tasty-turnaround-you-dont-want",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-18T15:45:02.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/markets/stocks/articles/red-robin-stock-middle-tasty-154502569.html"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "An2 Therapeutics director Robin Readnour sells $212,701 in common stock",
        "url": "https://urgent.news/2026/08/19/an2-therapeutics-director-robin-readnour-sells-212-701-in-common-stock",
        "published": "2026-08-19T22:30:57.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}